LTF and irritable bowel syndrome: Langhorst et al.33 revealed increased levels of human β-defensin-2 in the feces of IBS patients in the absence of macroscopic inflammation, as levels of fecal calprotectin and lactoferrin did not differ between healthy controls and patients with IBS.